"Somatostatin and its receptors from fish to mammals"
Most guidelines support the use of metformin in people with an eGFR of 30 mL/min/1.73 m 2 or greater (although not at maximum recommended doses) and that there is a growing appreciation of temporarily withholding SGLT-2 inhibitors when patients are unwell or need to fast for a prolonged period of time to prevent the development of euglycaemic diabetic ketoacidosis
Melanoma Risk The relationship between MT-2 and melanoma is not definitively established, but the theoretical concern is significant: MT-2 stimulates melanocyte proliferation the same cell type that becomes malignant in melanoma At least 4 case reports link MT-2 use to melanoma diagnosis (Hjuler et al., 2014) No long-term safety data exists MT-2 has never completed Phase III trials for tanning However, it's important to note: Case reports cannot establish causation MT-2 users are often the same population that uses tanning beds (an established melanoma risk factor) The FDA-approved MT-1 (afamelanotide), which works through the same MC1R pathway, has not shown melanoma signals in clinical trials Bottom line: The risk is theoretical but plausible
It targets hyperpigmentation, dark s
[CrossRef] [PubMed] [Google Scholar] Rosacea, an infectious disease: Why rosacea with papulopustules should be considered a demodicosis A narrative review
Role of lipid peroxidation in cellular responses to D,L-sulforaphane, a promising cancer chemopreventive agent
